Homocysteine (Hcy) and S-adenosylhomocysteine (AdoHcy) are critical intermediates of methionine metabolism. To investigate which, if either, of these compounds is more closely related to atherosclerosis, we fed 5 groups of apolipoprotein E (apoE)-deficient mice different diets for 8 wk to induce changes in their plasma Hcy and AdoHcy concentrations. These included an AIN-93G control diet (C), this C diet supplemented with methionine (M), the M diet deficient in folates, vitamin B-6, and vitamin B-12 (M2V), this M diet supplemented with these B vitamins (M1V), and a C diet deficient in B vitamins (C2V). Compared with controls, mice fed the C2V diet had a moderate elevation in their plasma total Hcy (tHcy) levels; however, their plasma AdoHcy concentration and atherosclerotic lesion areas were not different. In contrast, the mice fed the M1V diet had larger atherosclerotic lesion areas and elevated plasma AdoHcy concentrations but their plasma tHcy concentration did not differ from that of the group C mice. The plasma AdoHcy concentration and aortic sinus lesion areas were positively correlated (r ¼ 0.866; P , 0.001). We observed a negative correlation between the plasma AdoHcy concentration and both the DNA methyltransferase activity (r ¼ 20.792; P , 0.001) and global DNA methylation status (r ¼ 20.824; P , 0.001) in the aortic tissue. Hence, our study suggests that plasma AdoHcy is a better biomarker of atherosclerosis than Hcy and may accelerate the development of atherosclerotic lesions in apoE-deficient mice that have been fed a high methionine diet. The mechanisms underlying this effect may be related to the AdoHcymediated inhibition of DNA methylation in the aortic tissue.
Introduction
Homocysteine (Hcy) 3 is a sulfur-containing amino acid that functions as an intermediate in methionine metabolism. The hypothesis that Hcy causes vascular diseases was first proposed by McCully in 1969 (1) and numerous epidemiological studies have since demonstrated that an increased concentration of total Hcy (tHcy) in plasma is an independent risk factor for atherothrombotic diseases (2) (3) (4) . However, the mechanisms underlying the onset of hyperhomocysteinemia related to atherogenesis remain largely unknown and it is still unclear whether a normalization of the elevated plasma tHcy levels can reduce the onset of cardiovascular disease (5, 6) .
A recent study by Troen et al. (7) has shown that the extent of atherosclerosis development is independent of the plasma tHcy concentration in apolipoprotein E (apoE)-deficient mice fed with methionine-enriched and B vitamin-deficient or -supplemented diets. This finding suggested that the atherogenesis induced by a high dietary intake of methionine involves complex pathogenic mechanisms and that plasma Hcy may be an indirect indicator of atherosclerotic lesions. More attention has recently been paid, however, to another metabolic intermediate of methionine, S-adenosylhomocysteine (AdoHcy), which is the sole metabolic precursor of Hcy in a reversible reaction catalyzed by AdoHcy hydrolase. In a recent case-control study, Kerins et al. (8) demonstrated that an elevation in the plasma AdoHcy concentration is a much more sensitive indicator of cardiovascular disease than elevations in the plasma Hcy levels. This suggested that the plasma AdoHcy concentration may be a better biomarker of atherosclerosis than Hcy. Additional studies will be needed in the future, however, to more precisely determine the role of AdoHcy in atherosclerosis.
Atherogenesis is thought to involve alterations in gene expression and the corresponding activities of their gene products.
Epigenetic changes, particularly aberrant DNA methylation, serve as an important mechanism that controls gene expression in a variety of chronic diseases. In this regard, AdoHcy is a potential inhibitor of DNA methyltransferase (Dnmt), which could thus affect the DNA methylation pattern. In accordance with this notion, 2 independent studies of patients with vascular disease have previously shown that the concentration of Hcy increases in parallel with AdoHcy in plasma and that these increases were associated with lymphocyte DNA hypomethylation (9, 10) . Hence, it appears that an AdoHcy-mediated inhibition of DNA methylation may have a profound impact on the pathogenesis of atherosclerosis. However, the effects of AdoHcy upon the methylation of specific genes related to atherosclerosis, or across the whole genome, have not been documented thus far.
Our study was designed to examine the effects of an elevated plasma AdoHcy concentration on atherosclerotic lesions in apoE-deficient mice fed high levels of dietary methionine and to determine whether AdoHcy is a better biomarker of atherosclerosis than Hcy. We further investigated the potential relationship between the plasma AdoHcy concentration and the methylation of aortic tissue DNA during the development of atherosclerosis in the same mouse model.
Materials and Methods
Mice and diets. Three-week-old male weanling apoE-deficient mice, which were purchased from Jackson Laboratories and maintained in our animal facility, were fed with a laboratory diet based on the AIN-93G formula (11) . At 8 wk of age, these mice were divided into 5 groups of 10 that were matched for body weight. Each group received 1 of the following diets: an AIN-93G diet (C); the C diet supplemented with methionine (M); the M diet deficient in folate, vitamin B-6, and vitamin B-12 (M2V); the M diet supplemented with these B vitamins (M1V); and the C diet deficient in B vitamins (C2V). These experimental diets were modified according to Troen et al. (7) using vitamin-free casein and other vitamin mixtures (Harlan TEKLAD) to ensure variety in the vitamin intake of the mice. The nutrients contained in the diet of each group are listed in Table 1 . All of the mice were then fed these experimental feeds for an additional 8 wk and had free access to both food and water. We weighed the mice every week and calculated the consumption of water and feed for each group. This study and all the procedures herein were approved by the Animal Care and Use Committee of Sun Yat-sen University.
Tissue preparation and atherosclerotic lesion analysis. After 8 wk of dietary intervention, the mice were food-deprived overnight and killed by exsanguination from the retro-orbital plexus. The hearts were then harvested intact and stored in 10% formalin buffer solution at 4°C. The whole length of the aorta was immediately snap-frozen in liquid nitrogen and stored at 280°C. Consecutive sections (8 mm) were cut through the aortic sinus where the valve cusp was visible and then stained with oil red O and counterstained with hematoxylin. The lesion area was measured by means of direct image capture from an RGB camera (JVCky-F 30B) and quantified using Optimas 4.1 software (12) . The detectable atherosclerotic lesion areas were expressed as the percentage of the total crosssectional vessel wall area and the mean lesion size from 5 sections was calculated for each mouse.
Serum vitamin B-6, vitamin B-12, and folate. Blood samples from the retro-orbital venous plexus were centrifuged at 1500 3 g; 15 min to obtain serum, which was then stored at 220°C for subsequent testing. The serum pyridoxal phosphate (vitamin B-6) concentration was determined by HPLC (13) (510; Waters). The levels of serum vitamin B-12 and folate were measured using a chemiluminescence immunoassay (ACS 180; Bayer).
Plasma tHcy and AdoHcy measurements. The blood samples used to measure the plasma tHcy and AdoHcy concentrations were collected in EDTA-containing tubes, which were centrifuged at 3000 3 g; 10 min within 30 min and stored at 220°C. Plasma tHcy concentrations were quantified using a fluorescence polarization immunoassay (Abbott IMx). For the estimation of the plasma AdoHcy concentration, we have developed a new method that is less time consuming than chromatographic separation. The principle of this technique is based on the competitive immunoassay using a monoclonal anti-AdoHcy antibody (14) . Briefly, thawed plasma samples were deproteinized by adding a 1/11 volume of 100% trichloroacetic acid. After incubation on ice for 30 min, supernatants were obtained by centrifugation at 18,000 g; 15 min at 4°C and transferred into the wells of an AdoHcy-coated microtiter plate. The chemicals utilized for the subsequent competitive immunoassay were purchased from Axis-Shield. We defined the quantification limit as 5 nmol/L and the reproducibility was consistent. Eight control standards for calibration were prepared by the addition of AdoHcy into control plasma at concentrations ranging from 5 to 200 nmol/L and then subjecting these controls to the same pretreatment procedures as the unknown samples to construct a calibration curve. A total of 200 mL of monoclonal anti-AdoHcy antibody was added to each well and the samples were incubated at room temperature for 30 min. The plate was then washed 4 times with 350 mL of phosphate buffer solution and 100 mL of a rabbit anti-mouse-antibody enzyme conjugate was then added to each sample. The plate was next incubated at room temperature for 20 min and each well was washed 4 times with 350 mL of phosphate buffer solution. After the addition of 100 mL of substrate solution to each sample well, the plate was incubated at room temperature for 10 min. The reaction was stopped by adding 100 mL of 0.8 mol/L sulfuric acid and the results were determined within 15 min by the absorbance at 450 nm. The absorbance values inversely correlate with the concentration of AdoHcy and this method showed a reliable recovery rate (90.8-107.4%).
Dnmt activity. Mouse aortas were prepared from which nuclear extracts were made using a Nuclear Protein Extraction kit (Beyotime Biotechnology). The protein concentrations were determined using the Bicinchoninic Acid assay kit (Beyotime Biotechnology). We quantified the total Dnmt activity levels using an innovative colorimetric assay with the EpiQuik DNA Methyltransferase Activity Assay kit (Epigentek Group). In this assay, the cytosine-rich DNA substrate is stably coated on the strip wells. These wells are then specifically treated to confer a high DNA adsorption ability. Dnmt transfers a methyl group from S-adenosylmethionine (AdoMet) to a cytosine in the DNA substrate. Methylated DNA can be recognized using an anti-5-methylcytosine antibody. The levels of methylated DNA, which were proportional to the enzymatic activity, were then colorimetrically quantified using an ELISA-like reaction. The results were expressed as absorbance units 450 nmÁh Global DNA methylation status. DNA was isolated from the aortas of the mice using the Dneasy Tissue kit (Qiagen). After adjusting the sample DNA concentration to 40 mg/L, the purified DNA was immobilized to a strip well with a high affinity for DNA. Assessment of the global DNA methylation status was accomplished using the Methylamp Global DNA Methylation Quantification kit (Epigentek Group). The methylated fraction of DNA was identified using 5-methylcytosine monoclonal antibodies and quantified by an ELISA-like reaction. The levels of methylated 
Results
Body weight and serum B vitamin levels. After receiving 1 of the 5 experimental diets for 8 wk, the mean body weights of the mice decreased in the dietary groups M2V (18.9 6 4.1 g) and C2V (20.4 6 3.7 g) compared with group C (24.9 6 4.0 g) (P , 0.05). The mice fed the M and M1V diets had a similar weight gain to the mice in group C. Dietary intakes did not differ among these groups. In addition, compared with the C diet, a dietary B vitamins deficiency (M2V and C2V diets) or enrichment (M1V diet) caused a significant decrease or increase, respectively, in the serum folate, vitamin B-6, and vitamin B-12 concentrations after 8 wk of feeding ( Table 2) .
Atherosclerotic lesions. We found that the methionine-rich diets increased the aortic sinus plaque areas compared with the control diet. The atherosclerotic lesion areas in the mice from dietary groups M, M2V, and M1V were 53, 95, and 37% greater, respectively, than those in group C (P , 0.01) (Fig. 1) .
Compared with mice in group C, atherosclerotic lesion areas in mice fed the C2V diet did not differ (P . 0.05).
Plasma tHcy and AdoHcy. Plasma tHcy concentrations were elevated in mice fed the M and C2V diets (P , 0.05) and a remarkable increase was observed in the M2V diet mice compared with group C (P , 0.001) ( Fig. 2A) . Two groups (M and M2V) had elevated plasma tHcy concentrations that accompanied the increased plaque sizes. However, mice fed a C2V diet had increased plasma tHcy concentrations but no increase in their lesion areas. In contrast, the plasma tHcy concentrations did not increase in the M1V diet mice, whereas the plaque sizes in this group were larger than those in group C. The concentrations of plasma AdoHcy were elevated as a result of the M, M1V, and M2V diets (P , 0.05) (Fig. 2B) . Interestingly, the variation in the plasma AdoHcy levels did not parallel that of the plasma tHcy concentrations in our current animal model system. Compared with group C, there was no detectable increment in the plasma AdoHcy concentrations (P . 0.05) but a moderate elevation in the plasma tHcy levels in group C2V. Mice fed the M1V diet had increased plasma AdoHcy concentrations (P , 0.05) but normal plasma tHcy concentrations. In addition, the M2V diet caused a severe increase (;17-fold) in the plasma tHcy concentrations compared with group C (P , 0.001) but only a moderate increase in the plasma AdoHcy concentration (2.83-fold) (P , 0.001). There was a positive correlation between the plasma AdoHcy concentrations, but not the plasma tHcy levels, and the aortic sinus lesion areas in all of the dietary groups (r ¼ 0.866; P , 0.001).
Total Dnmt activity and global DNA methylation analysis.
Compared with the C diet mice, the M2V diet-fed mice had a 28% reduction in Dnmt activity in their aortic tissue (P , 0.05) and this was associated with the highest concentrations of plasma AdoHcy (Fig. 3A) . In contrast, the C2V diet group had normal AdoHcy concentrations and Dnmt activity did not differ from the C diet-fed mice (P . 0.05). We also found a negative correlation between the plasma AdoHcy concentration and Dnmt activity in all groups (r ¼ 20.824; P , 0.001) but no such correlation between tHcy and Dnmt. Consistent with their decreased Dnmt activity levels, the global DNA methylation status of the aortic tissue was reduced in groups M, M2V, and M1V compared with group C (P , 0.01) (Fig. 3B) . 
Discussion
Numerous epidemiological investigations have now demonstrated that a mild elevation in the plasma Hcy concentration is associated with an increased risk of vascular disease and that this is independent of other risk factors (15) (16) (17) (18) (19) (20) (21) . However, data from other case-control studies do not support such a causal relationship and the mechanism of Hcy-related atherosclerosis still remains insufficiently understood. In fact, it is still unknown whether Hcy is itself a causal factor or just an indirect metabolic marker of some of the biochemical processes that occur in atherosclerosis (22) (23) (24) . There are a number of intermediates of methionine metabolism, including AdoMet, AdoHcy, and Hcy, and recent studies have shown that a high AdoHcy concentration or low AdoMet:AdoHcy ratio may be more directly related to vascular damage than Hcy (8) (9) (10) 25) . Another study by Troen et al. (7) has reported that the extent of atherosclerosis in apoEdeficient mice is in fact independent of the plasma tHcy concentration. However, the authors in this case did not explore whether the plasma AdoHcy levels correlated with atherosclerotic plaque formation. In this study, we confirmed that elevated plasma tHcy is not closely associated with the extent of atherosclerotic lesions in our apoE-deficient mice models but that AdoHcy is a good marker of this disease. When these mice were fed the C2V diet, they had no increase in their atherosclerotic lesion areas and a normal range of plasma AdoHcy concentrations but their plasma tHcy concentrations were moderately elevated. In contrast, atherogenesis was accelerated in mice fed the M1V diet and they also had elevated plasma AdoHcy concentrations, even though they had normal concentrations of plasma tHcy. This result provided further evidence that the plasma tHcy concentration is not closely associated with atherosclerotic lesions in apoE-deficient mice, consistent with the previous findings of Troen et al. (7) . Hence, our data do not support Hcy as an independent risk factor of atherosclerosis. We then analyzed the association of AdoHcy and tHcy with spontaneously atheromatous lesion progression in apoE-deficient mice fed experimental diets that varied in methionine and B vitamin contents. Importantly, the plasma AdoHcy concentrations, but not the plasma tHcy levels, were consistently correlated with the extent of atherosclerosis. Our results thus suggest for the first time, to our knowledge, that plasma AdoHcy is a far better biomarker of atherosclerosis than Hcy and may be causally linked to the pathogenesis of this vascular disease.
Epigenetic changes have been recognized as an important mechanism during oncogenesis, but insufficient data has so far been provided that link this mechanism to the pathophysiology of atherogenesis (26) (27) (28) . It is well known that methylation is an important epigenetic feature of DNA that is catalyzed by Dnmt with AdoMet serving as a methyl donor. AdoHcy is a known potent inhibitor of the methyltransferases, including Dnmt, by binding to these enzymes with higher affinity than AdoMet. The accumulation of AdoHcy causes a feedback inhibition of AdoMet-dependent methyltransferases, which can affect the DNA methylation pattern and lead to promotion of chronic diseases (28) (29) (30) (31) . Recently, Castro et al. (9) confirmed that genomic DNA hypomethylation was strictly dependent on the intracellular AdoHcy content in human umbilical vein endothelial cells. Yi et al. (10) have also demonstrated that increased plasma tHcy content correlates with increased plasma AdoHcy, which in turn correlates with its intracellular concentration and with the extent of lymphocyte DNA hypomethylation. These findings suggest that the AdoHcy levels are a major predictor of reduced methylation capacity and may be involved in the pathogenesis of chronic diseases.
The results of our study indicate that negative correlations exist between the plasma AdoHcy concentration and Dnmt activity and between the plasma AdoHcy concentration and global DNA hypomethylation in atherosclerotic mice. This in turn indicates that variations in the plasma AdoHcy levels may reflect changes in the intracellular concentrations of this molecule and consequently lead to global DNA hypomethylation in the aortic tissue of this mouse model. Thus, the inhibitory effects of AdoHcy on the methyltransferases may potentially be an important pathogenic mechanism in the development of atherosclerosis. The future determination of intracellular AdoHcy concentrations of aortic tissue will provide direct evidence to support this possibility.
The CpG island hypermethylation of specific genes has been linked to tumor suppressor gene silencing, whereas DNA hypomethylation has been proposed to cause oncogenic mutations by promoting chromosomal instability. The study of epigenetic mechanisms in atherosclerosis has only just begun, and there are few reports that have focused on alterations in the DNA methylation of specific genes related to atherosclerosis. Thus far, the CpG island hypermethylation of the estrogen receptor gene, an antiproliferative gene, has been reported to be associated with atherosclerosis (32) . In this study, we did not determine the DNA methylation pattern for specific atherosclerosis-susceptible genes or atherosclerosis-protective genes related to atherosclerotic progression. Subsequent studies will therefore be needed to further validate our findings.
In summary, our study demonstrates that an elevated plasma AdoHcy concentration is a better biomarker of atherosclerosis than the plasma Hcy levels and that AdoHcy may play a role in promoting atherosclerotic lesions in apoE-deficient mice fed a high methionine diet. The mechanisms underlying the atherogenic effects of AdoHcy may also be associated with its inhibition of DNA methylation in aortic tissue.
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